EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Vietnam Medicinal Materials JSC EBITDA Margin % Related Terms
Vietnam Medicinal Materials JSC EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HSTC:DVM vs ZTS, UTHR, VTRS: EBITDA Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Vietnam Medicinal Materials JSC's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vietnam Medicinal Materials JSC EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vietnam Medicinal Materials JSC's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Vietnam Medicinal Materials JSC's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vietnam Medicinal Materials JSC (HSTC:DVM) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Vietnam Medicinal Materials JSC and its competitors. According to the industry distribution chart, Vietnam Medicinal Materials JSC ranks #999999 out of 953 companies in the Drug Manufacturers industry.
Is Vietnam Medicinal Materials JSC's EBITDA Margin % too high?
Vietnam Medicinal Materials JSC's current EBITDA Margin % is 0.00%. Based on the distribution chart, Vietnam Medicinal Materials JSC ranks #999999 out of 953 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Vietnam Medicinal Materials JSC has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Vietnam Medicinal Materials JSC's EBITDA Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vietnam Medicinal Materials JSC ranks #999999 out of 953 companies for EBITDA Margin %. This places Vietnam Medicinal Materials JSC in the lower half of its industry. The industry median EBITDA Margin % is 12.54. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.54, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Vietnam Medicinal Materials JSC and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vietnam Medicinal Materials JSC's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vietnam Medicinal Materials JSC stock overvalued right now?
Vietnam Medicinal Materials JSC (HSTC:DVM) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Vietnam Medicinal Materials JSC's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Vietnam Medicinal Materials JSC (HSTC:DVM), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vietnam Medicinal Materials JSC Business Description
Vietnam Medicinal Materials JSC is a company specializing in clean medicinal herbs and is committed to pharmaceuticals and health food products derived from natural medicinal herbs, with product quality as a top priority. Its business areas are the production and wholesale of medicinal herbs. Its activities include manufacturing and trading of pharmaceuticals, cultivation and processing of medicinal herbs, dietary supplements, wholesale and retail of medical products, cosmetics and equipment, and import and export of goods traded by the company. Its products are developed from standardized medicinal herbs under controlled cultivation, harvesting and processing, combining traditional remedies with science under strict quality control.
32GF Score
Get the complete analysis for HSTC:DVM
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSTC:DVM has been successfully added to your 